Ascendis Pharma A/S Ordinary Share (ASND) Technical Analysis
$223.13
Market is closed - opens 7 PM, 24 Sep 2026
Insights
- Ascendis Pharma A/S is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Ascendis Pharma A/S stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Ascendis Pharma A/S stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for Ascendis Pharma A/S stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 30.41 | Neutral |
Stochastic | 4.89, 15.32 | Neutral |
Ultimate Oscillator | 33.17 | Neutral |
Stochastic Relative Strength Index | 3.67, 4.46 | Neutral |
Moving Average Convergence Divergence | -5.68, -1.8 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 245.12 | Sell |
20 | 253.09 | Buy |
50 | 252.77 | Buy |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 242.01 | Sell |
20 | 248.11 | Sell |
50 | 250.45 | Buy |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 242.24 | Sell |
20 | 249.48 | Sell |
50 | 250.82 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 232.53 | Sell |
20 | 241.91 | Sell |
50 | 252.49 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 227.18 | Sell |
20 | 235.62 | Sell |
50 | 248.18 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 246.64 |
Resistance L2 | 243.66 |
Resistance L1 | 240.62 |
Pivot Point | 237.64 |
Support L1 | 234.6 |
Support L2 | 231.62 |
Support L3 | 228.58 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.